(Total Views: 225)
Posted On: 01/26/2022 2:03:41 PM
Post# of 250610
$QNTA trading low volume compared to its 10-day average volume with less than 2 hours left in the day... Looking forward to seeing updates on the meeting with the FDA.
End of January, the Company also plans to request a meeting with the United States (“US”) Food & Drug Administration (“FDA”) in order to explore the possibility of a change from PIND to IND status and approving Escozine for a 30-to-60 patient pilot study to show proof of concept within the US.
End of January, the Company also plans to request a meeting with the United States (“US”) Food & Drug Administration (“FDA”) in order to explore the possibility of a change from PIND to IND status and approving Escozine for a 30-to-60 patient pilot study to show proof of concept within the US.
(0)
(0)Scroll down for more posts ▼
